Banner
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 History
 Advertising
 
Have you been tested for sickle cell trait? Know your status!
 
Bone health resources at your fingertips.
 
Jobs
 


Industry News

LabConnect: Assistance for sites. Assurance for sponsors.

Search Articles: 
  • Chugai receives Orphan Drug designation for TECENTRIQ in SCLC Chugai Pharm announced that humanized anti-PD-L1 monoclonal antibody TECENTRIQ® Intravenous Infusion 1200 mg [atezolizumab (genetical recombination)], and ROS1/TRK inhibitor entrectinib which is under development, received orphan drug designation by the Ministry of Health for treatment of SCLC.
    December 06, 2018

More...

 
Email thie page to a friend. Email This Page
to a Friend 		Print this page. Print This
Page
© 1997 - 2019 Info.Resource, Inc. All rights reserved.
Privacy Policy & Cookies . Terms of Use . About . Advertising

BritishColumbiaLifeScience.com is owned and published by Info.Resource, Inc.